Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A FitzGerald

Showing results (51-60 of 310) with videos related to

Pageof 31
Sort By:
Clinical Pharmacology and Therapeutics|January 1, 1985
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosingA K Pedersen, G A FitzGerald
Irish Medical Journal|August 31, 1979
One hundred days in a general medical/specialist unit--sources of referral and length of hospital stayG A Fitzgerald, M I Drury
Thrombosis Research|February 15, 1986
Eicosenoid biosynthesis and platelet function with advancing ageI A Reilly, G A FitzGerald
Free Radical Biology & Medicine|August 18, 2000
Indices of lipid peroxidation in vivo: strengths and limitationsE A Meagher, G A FitzGerald
Trends in Cardiovascular Medicine|November 1, 2001
Oxidative stress. IntroductionG A FitzGerald, J L Witztum
Trends in Cardiovascular Medicine|January 18, 2011
Antiplatelet and anticoagulant therapy during coronary thrombolysisD J Fitzgerald, G A Fitzgerald
Drug Safety|August 1, 1995
Long-term aspirin in the prevention of cardiovascular disorders. Recent developments and variations on a themeF Catella-Lawson, G A FitzGerald
Circulation|September 1, 1993
Disordered eicosanoid formation in pregnancy-induced hypertensionE A Meagher, G A FitzGerald
The Journal of Biological Chemistry|July 5, 1991
Eicosanoid forming enzyme mRNA in human tissues. Analysis by quantitative polymerase chain reactionC D Funk, G A FitzGerald
JAMA|June 15, 1984
Biosynthesis of thromboxane A2 in renovascular hypertensionG A FitzGerald, D J Fitzgerald
Pageof 31

Showing results (51-60 of 310) with videos related to

Sort By:
Pageof 31
Clinical Pharmacology and Therapeutics|January 1, 1985
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosingA K Pedersen, G A FitzGerald
Irish Medical Journal|August 31, 1979
One hundred days in a general medical/specialist unit--sources of referral and length of hospital stayG A Fitzgerald, M I Drury
Thrombosis Research|February 15, 1986
Eicosenoid biosynthesis and platelet function with advancing ageI A Reilly, G A FitzGerald
Free Radical Biology & Medicine|August 18, 2000
Indices of lipid peroxidation in vivo: strengths and limitationsE A Meagher, G A FitzGerald
Trends in Cardiovascular Medicine|November 1, 2001
Oxidative stress. IntroductionG A FitzGerald, J L Witztum
Trends in Cardiovascular Medicine|January 18, 2011
Antiplatelet and anticoagulant therapy during coronary thrombolysisD J Fitzgerald, G A Fitzgerald
Drug Safety|August 1, 1995
Long-term aspirin in the prevention of cardiovascular disorders. Recent developments and variations on a themeF Catella-Lawson, G A FitzGerald
Circulation|September 1, 1993
Disordered eicosanoid formation in pregnancy-induced hypertensionE A Meagher, G A FitzGerald
The Journal of Biological Chemistry|July 5, 1991
Eicosanoid forming enzyme mRNA in human tissues. Analysis by quantitative polymerase chain reactionC D Funk, G A FitzGerald
JAMA|June 15, 1984
Biosynthesis of thromboxane A2 in renovascular hypertensionG A FitzGerald, D J Fitzgerald
Pageof 31